A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
CompletedPhase 4NCT02289261
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine whether dexmedetomidine added to morphine is effective in the treatment of chronic cancer pain.
Study details
- Official title
- A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
- Conditions
- Interventions
- Drug: Morphine
- Drug: Morphine plus dexmedetomidine
- Sponsor
- Cukurova University
- Start date
- 2014-11
- Primary completion
- 2015-02
- Sex
- All
- Age range
- from 20 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients with chronic cancer pain * between 20-80 years old age Exclusion Criteria: * the presence of severe systemic disease(cardiac, pulmonary, hepatic or renal) * psychiatric or neurologic disease * unable to communicate verbally * nausea and vomiting * patient's refusal
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02289261